Lista de obras - Edward K Chow - Dominio Público Uruguay

3D Culture as a Clinically Relevant Model for Personalized Medicine

article

A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections

artículo científico publicado en 2006

Accelerating the Translation of Nanomaterials in Biomedicine

artículo científico publicado en 2015

Artificial Intelligence-Driven Designer Drug Combinations: From Drug Development to Personalized Medicine

article

Biocompatibility Assessment of Detonation Nanodiamond in Non-Human Primates and Rats Using Histological, Hematologic, and Urine Analysis

artículo científico publicado en 2016

Cancer nanomedicine: from drug delivery to imaging

artículo científico publicado en 2013

Clinical Applications of Carbon Nanomaterials in Diagnostics and Therapy

artículo científico publicado en 2018

Copolymeric nanofilm platform for controlled and localized therapeutic delivery

artículo científico publicado en 2008

Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression

artículo científico publicado en 2013

Diamonds, Digital Health, and Drug Development: Optimizing Combinatorial Nanomedicine

artículo científico publicado en 2016

Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection

artículo científico publicado en 2004

Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity

scientific article published on 23 April 2019

E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60.

artículo científico publicado en 2015

Epigenetics in cancer stem cells

scientific article published on February 2017

Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells

artículo científico publicado en 2014

Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges

artículo científico publicado en 2017

Identification and Optimization of Combinatorial Glucose Metabolism Inhibitors in Hepatocellular Carcinomas

artículo científico publicado en 2015

Implication of cancer stem cells in cancer drug development and drug delivery

artículo científico

Innate immune system regulation of nuclear hormone receptors in metabolic diseases

artículo científico publicado en 2007

Mechanisms of chemoresistance in cancer stem cells

artículo científico publicado en 2013

Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic efficacy

artículo científico publicado en 2011

Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment

artículo científico publicado en 2011

Nanodiamond-Manganese dual mode MRI contrast agents for enhanced liver tumor detection

artículo científico publicado en 2016

Nanodiamond-mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cells

artículo científico publicado en 2014

Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine

artículo científico publicado en 2015

Nanomedicine for global health

artículo científico publicado en 2014

Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells

artículo científico publicado en 2012

Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)

artículo científico publicado en 2018

Polyinosinic-polycytidylic acid suppresses acetaminophen-induced hepatotoxicity independent of type I interferons and toll-like receptor 3

artículo científico publicado en 2011

Reciprocal interaction of Wnt and RXR-α pathways in hepatocyte development and hepatocellular carcinoma

artículo científico publicado en 2015

Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia

artículo científico publicado en 2013

TIP60 inhibits metastasis by ablating DNMT1-SNAIL2-driven epithelial-mesenchymal transition program.

artículo científico publicado en 2016

TLR agonists regulate PDGF-B production and cell proliferation through TGF-beta/type I IFN crosstalk

artículo científico publicado en 2005

Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4

artículo científico publicado en 2003

Toll-like receptors induce a phagocytic gene program through p38.

artículo científico publicado en 2003

Triggered release of therapeutic antibodies from nanodiamond complexes

artículo científico publicado en 2011

Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice

artículo científico publicado en 2009

Lista de obras de Edward K Chow

3D Culture as a Clinically Relevant Model for Personalized Medicine

A role for IRF3-dependent RXRalpha repression in hepatotoxicity associated with viral infections

Accelerating the Translation of Nanomaterials in Biomedicine

Artificial Intelligence-Driven Designer Drug Combinations: From Drug Development to Personalized Medicine

Biocompatibility Assessment of Detonation Nanodiamond in Non-Human Primates and Rats Using Histological, Hematologic, and Urine Analysis

Cancer nanomedicine: from drug delivery to imaging

Clinical Applications of Carbon Nanomaterials in Diagnostics and Therapy

Copolymeric nanofilm platform for controlled and localized therapeutic delivery

Diamond-lipid hybrids enhance chemotherapeutic tolerance and mediate tumor regression

Diamonds, Digital Health, and Drug Development: Optimizing Combinatorial Nanomedicine

Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection

Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity

E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60.

Epigenetics in cancer stem cells

Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells

Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges

Identification and Optimization of Combinatorial Glucose Metabolism Inhibitors in Hepatocellular Carcinomas

Implication of cancer stem cells in cancer drug development and drug delivery

Innate immune system regulation of nuclear hormone receptors in metabolic diseases

Mechanisms of chemoresistance in cancer stem cells

Multimodal nanodiamond drug delivery carriers for selective targeting, imaging, and enhanced chemotherapeutic efficacy

Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment

Nanodiamond-Manganese dual mode MRI contrast agents for enhanced liver tumor detection

Nanodiamond-mitoxantrone complexes enhance drug retention in chemoresistant breast cancer cells

Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine

Nanomedicine for global health

Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells

Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)

Polyinosinic-polycytidylic acid suppresses acetaminophen-induced hepatotoxicity independent of type I interferons and toll-like receptor 3

Reciprocal interaction of Wnt and RXR-α pathways in hepatocyte development and hepatocellular carcinoma

Synthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemia

TIP60 inhibits metastasis by ablating DNMT1-SNAIL2-driven epithelial-mesenchymal transition program.

TLR agonists regulate PDGF-B production and cell proliferation through TGF-beta/type I IFN crosstalk

Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4

Toll-like receptors induce a phagocytic gene program through p38.

Triggered release of therapeutic antibodies from nanodiamond complexes

Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice